Hence we here developed and employed novel cell-based assays allowing to functionally monitor the effects of overexpressing catalytically inactive or attenuated Taspase1 mutants on Taspase1’s processing of AF4•MLL in living cancer cells in real time. Here, AFF1 is linked to cancer.